{"mainPropery":{"diseaseId":10973,"diseaseName":"Adult neuronal ceroid lipofuscinosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10973/adult-neuronal-ceroid-lipofuscinosis","synonyms":["Adult NCL","Kuf's disease","ANCL","Neuronal ceroid lipofuscinosis 4","CLN4 disease, adult autosomal dominant","Kufs disease"],"synonyms-with-source":[{"name":"Adult NCL"},{"name":"Kuf's disease"},{"name":"ANCL"},{"name":"Neuronal ceroid lipofuscinosis 4"},{"name":"CLN4 disease, adult autosomal dominant","source":"GeneReviews"},{"name":"Kufs disease","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"79262"}]},"diseaseCategories":[],"organizations":[{"resourceID":315,"resourceName":"Batten Disease Support and Research Association","abbreviation":"BDSRA","address1":"2780 Airport Drive, Suite 342","address2":"","address3":"","address4":"","address5":"","city":"Columbus","state":"OH","zip":"43219","country":"United States","phone":"","tty":"","tollFree":"1-800-448-4570","fax":"1-866-648-8718","email":"https://bdsra.org/contact-us/","url":"https://bdsra.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%22Adult%20neuronal%20ceroid%20lipofuscinosis%22%5BTIAB%5D%20OR%20Kufs%20disease%5BTIAB%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Adult neuronal ceroid lipofuscinosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://clinicaltrials.gov/ct2/results?term=%22Adult+neuronal+ceroid+lipofuscinosis%22&Search=Search' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Adult neuronal ceroid lipofuscinosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/kufs-disease' target='_blank'>MedlinePlus Genetics</a> contains information on Adult neuronal ceroid lipofuscinosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0022797/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/kufs-disease/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001613.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/batten/detail_batten.htm' target='_blank'>National Institute of Neurological Disorders and Stroke (NINDS)</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1178391-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79262' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1428/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:79262' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Adult neuronal ceroid lipofuscinosis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Adult neuronal ceroid lipofuscinosis:<br />\r\n<a href='https://www.urmc.rochester.edu/neurology/batten-disease-center/research/research-clinical-trials.aspx' target='_blank'>Batten Disease Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":6567,"questionText":"What is adult neuronal ceroid lipofuscinosis?","answerText":"<strong>Adult neuronal ceroid lipofuscinosis </strong>is a rare condition that affects the nervous system. Signs and symptoms usually begin around age 30, but they can develop anytime between adolescence and late adulthood. There are two forms of adult neuronal ceroid lipofuscinosis that are differentiated by their underlying genetic cause, mode of inheritance and certain symptoms:[5653][9561][9562]<br />\r\n<br />\r\n<ul>\r\n    <li><em>Type A</em> is characterized by a combination of seizures and uncontrollable muscle jerks (myoclonic epilepsy); <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000739.htm\" target=\"_blank\">dementia</a>; difficulties with muscle coordination (ataxia); involuntary movements such as tremors or tics; and <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=\"_blank\">dysarthria</a>. It is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/CLN6\" target=\"_blank\">CLN6</a></em> or <em><a href=\"http://ghr.nlm.nih.gov/gene/PPT1\" target=\"_blank\">PPT1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.</li>\r\n    <br />\r\n    <li><em>Type B</em> shares many features with type A; however, affected people also experience behavioral abnormalities and do not develop myoclonic epilepsy or dysarthria. It can be caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/DNAJC5\" target=\"_blank\">DNAJC5</a></em> or <em><a href=\"http://ghr.nlm.nih.gov/gene/CTSF\" target=\"_blank\">CTSF</a></em> gene  and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.</li>\r\n</ul>\r\n<br />\r\nTreatment options for adult neuronal ceroid lipofuscinosis are limited to therapies that can help relieve some of the symptoms.[9561][9562]","dateModified":"2015-08-30T00:00:00"},"basicQuestions":[{"questionId":6566,"questionText":"What is the long-term outlook for people with adult&nbsp;neuronal ceroid lipofuscinosis?","answerText":"Unfortunately, the long-term outlook (prognosis) for people with adult neuronal ceroid lipofuscinosis is generally poor. The symptoms tend to become worse over time, resulting in a shortened life expectancy. Most sources state that a person with adult neuronal ceroid lipofuscinosis usually lives about 10 years after the symptoms begin.[5653][9561]","dateModified":"2015-08-31T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5653,"authors":"","articleTitle":"Kufs disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/kufs-disease","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9561,"authors":"Mole SE, Williams RE","articleTitle":"Neuronal Ceroid-Lipofuscinoses","bookWebsiteJournalTitle":"GeneReviews","date":"August 1, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1428/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6845,"relatedDiseaseName":"Autosomal recessive neuronal ceroid lipofuscinosis 4A","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":10739,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13705,"phenoTypeName":"Abnormality of extrapyramidal motor function","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13747,"phenoTypeName":"Generalized myoclonic seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11418,"phenoTypeName":"Motor deterioration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11400,"phenoTypeName":"Orofacial dyskinesia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6018,"phenoTypeName":"Psychotic episodes","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Adult_neuronal_ceroid_lipofuscinosis"}